Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Mol Cell Biol. 2012 Dec;32(24):5067-77. doi: 10.1128/MCB.00610-12. Epub 2012 Oct 15.
Adipogenesis is an important component of adipose tissue development and is critically related to obesity. A cascade of transcription factors is involved in adipogenesis, in which peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer-binding proteins (C/EBPs) play pivotal roles. Bone morphogenetic proteins (BMPs) and Smad proteins are implicated in this cascade, although the precise regulatory mechanisms have yet to be elucidated. Here, we show that Tob2, a member of the Tob/BTG antiproliferative protein family, inhibits adipogenesis by interfering with Smad signaling. tob2 expression is downregulated in the white adipose tissue of high-fat diet-induced or genetically mutated obese mice. Consistent with this, tob2(-/-) mice exhibit increased adiposity with augmented expression of the genes encoding the type 1A BMP receptor (BMPR1A) and PPARγ2 as well as their target genes. We further show accelerated adipogenesis in primary tob2(-/-) preadipocytes. Furthermore, exogenously expressed Tob2 inhibits adipogenic differentiation of 3T3-L1 preadipocytes: the Tob2 protein suppresses PPARγ2 transcription by inhibiting BMP2-induced Smad1/5 phosphorylation through its interaction with Smad6 and by sequestering C/EBPα from the PPARγ2 promoter. Thus, Tob2 negatively regulates adipogenesis by inhibiting PPARγ2 expression.
脂肪生成是脂肪组织发育的重要组成部分,与肥胖密切相关。一系列转录因子参与脂肪生成,其中过氧化物酶体增殖物激活受体γ(PPARγ)和 CCAAT/增强子结合蛋白(C/EBPs)起着关键作用。骨形态发生蛋白(BMPs)和 Smad 蛋白也参与了这一过程,尽管确切的调控机制尚未阐明。在这里,我们表明 Tob2,一种 Tob/BTG 抗增殖蛋白家族的成员,通过干扰 Smad 信号通路来抑制脂肪生成。 Tob2 的表达在高脂肪饮食诱导或基因突变肥胖小鼠的白色脂肪组织中下调。与此一致的是, tob2(-/-) 小鼠表现出增加的肥胖,其编码 1A 型 BMP 受体(BMPR1A)和 PPARγ2 及其靶基因的基因表达增加。我们进一步表明, tob2(-/-) 前脂肪细胞中的脂肪生成加速。此外,外源性表达的 Tob2 抑制 3T3-L1 前脂肪细胞的脂肪生成分化: Tob2 蛋白通过其与 Smad6 的相互作用抑制 BMP2 诱导的 Smad1/5 磷酸化,从而抑制 PPARγ2 转录,并将 C/EBPα 从 PPARγ2 启动子上隔离,从而抑制 PPARγ2 表达。因此, Tob2 通过抑制 PPARγ2 表达来负调控脂肪生成。